Potential antiosteoporotic agents from plants: A comprehensive review

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Jia, Min ^a   Nie, Yan ^a,b   Cao, Da Peng ^a   Xue, Yun Yun ^a   Wang, Jie Si ^a   Zhao, Lu ^a   Rahman, Khalid ^c   Zhang, Qiao Yan ^a   Qin, Lu Ping ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACHYRANTHES BIDENTATA EXTRACT; ARTEMISIA IWAYOMOGI EXTACT; BERBERIS ARISTATA EXTRACT; CIBOTIUM BAROMETZ EXTRACT; CNIDIUM MONNIERI EXTRACT; CUMINUM CYMINUM EXTRACT; CURCULIGO ORCHIOIDES EXTRACT; CUSCUTA CHINENSIS EXTRACT; DAVALLIA FORMOSANA EXTRACT; DIOSCOREA SPONGIOSA EXTRACT; DIPSACUS ASPEROIDES EXTRACT; ELEUTHEROCOCCUS SENTICOSUS EXTRACT; EPIMEDIUM BREVICORNU EXTRACT; EPIMEDIUM EXTRACT; EPIMEDIUM KOREANUM EXTRACT; EPIMEDIUM PUBESCENS EXTRACT; EPIMEDIUM SAGITTATUM EXTRACT; FERULA HERMONIS EXTRACT; ICARIIN; IKARISOSIDE A; LEPIDIUM MEYENII EXTRACT; PANAX NOTOGINSENG EXTRACT; PLANT EXTRACT; PLATYCODON GRANDIFLORUM EXTRACT; SAFFLOWER EXTRACT; SAMBUCUS WILLIAMSII EXTRACT; SILYBUM MARIANUN EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINIUM ANGUSTIFOLIUM EXTRACT; WEDELIA CALENDULACEA EXTRACT;

ACHYRANTHES BIDENTATA; ANTIOSTEOPOROSIS ACTIVITY; ARTEMISIA IWAYOMOGI; ARTHROPATHY; BERBERIS ARISTATA; BONE DISEASE; BONE METABOLISM; BREAST TENDERNESS; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CIBOTIUM BAROMETZ; CLINICAL EFFECTIVENESS; COUGHING; CUMIN; CURCULIGO ORCHIOIDES; DAVALLIA FORMOSANA; DIABETES MELLITUS; DIARRHEA; DIOSCOREA SPONGIOSA; DIPSACUS ASPEROIDES; DRUG ACTIVITY; DRUG EFFICACY; DYSMENORRHEA; DYSPNEA; ECCHYMOMA; ELEUTHEROCOCCUS SENTICOSUS; EPILEPSY; EPIMEDIUM; EPIMEDIUM BREVICORNU; EPIMEDIUM KOREANUM; EPIMEDIUM PUBESCENS; EPIMEDIUM SAGITTATUM; FERULA HERMONIS; FRACTURE; HEPATITIS; HOT FLUSH; HUMAN; HYPERTENSION; IMPOTENCE; INFLAMMATION; ISCHEMIC HEART DISEASE; JAUNDICE; LEUKORRHEA; LIVER DISEASE; LOW BACK PAIN; MEDICINAL PLANT; MENOPAUSAL SYNDROME; MENORRHAGIA; MUSCLE INJURY; NEPHRITIS; NONHUMAN; OSTEOPOROSIS; PANAX NOTOGINSENG; POLYURIA; PRIORITY JOURNAL; PROSPERMIA; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SAFFLOWER; SAMBUCUS WILLIAMSII; SEXUAL DYSFUNCTION; SILYBUM MARIANUN; SOYBEAN; TINNITUS; TOOTH PAIN; TRACHEITIS; TRADITIONAL MEDICINE; UTERUS BLEEDING; VACCINIUM ANGUSTIFOLIUM; VAGINAL DRYNESS; WEDELIA CALENDULACEA;

EID: 84872815720     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/364604     Document Type: Review

References (209)

1. Sambrook P., Cooper C., Osteoporosis. Lancet 2006 367 9527 2010 2018 2-s2.0-33744992495 10.1016/S0140-6736(06)68891-0 (Pubitemid 43867702)
2. Rachner T. D., Khosla S., Hofbauer L. C., Osteoporosis: now and the future. The Lancet 2011 377 9773 1276 1287 2-s2.0-79953751008 10.1016/S0140-6736(10)62349-5
3. Enriori P. J., Enriori C. L., The pathogenesis of osteoporosis in older women and men: a review. Journal of Steroid Biochemistry and Molecular Biology 2002 82 1 1 6 2-s2.0-0036757260 10.1016/S0960-0760(02)00144-9 (Pubitemid 35341396)
4. Tremollieres F., Ribot C., Bone mineral density and prediction of non-osteoporotic disease. Maturitas 2010 65 4 348 351 2-s2.0-77649188155 10.1016/j.maturitas.2009.12.023
5. Gallagher J. C., Advances in bone biology and new treatments for bone loss. Maturitas 2008 60 1 65 69 2-s2.0-45649084098 10.1016/j.maturitas.2008.04. 005
6. Teitelbaum S. L., Bone: the conundrum of glucocorticoid-induced of osteoporosis. Nature Reviews Endocrinology 2012 8 8 451 452
7. Moutsatsou P., Kassi E., Papavassiliou A. G., Glucocorticoid receptor signaling in bone cells. Trends in Molecular Medicine 2012 18 6 348 359
8. Müller D., Pulm J., Gandjour A., Cost-effectiveness of different strategies for selecting and treating individuals at increased risk of osteoporosis or osteopenia, a systematic review. Value in Health 2012 15 2 284 298
9. Body J. J., Bergmann P., Boonen S., Devogelaer J. P., Gielen E., Goemaere S., Kaufman J. M., Rozenberg S., Reginster J. Y., Extraskeletal benefits and risks of calcium, Vitamin D and anti-osteoporosis medications. Osteoporosis International 2012 23 supplement 1 1 23 10.1007/s00198-011-1891-8
10. Davey D. A., Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause. Womens Health 2012 8 2 169 189
11. annitti T. I., Rosini S., Lodi D., Frediani B., Rottigni V., Palmieri B., Bisphosphonates: focus on inflammation and bone loss. American Journal of Therapeutics 2012 19 3 228 246
12. Komm B. S., Chines A. A., An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis. Maturitas 2012 71 3 221 226
13. Saito M., Marumo K., The effects of parathyroid hormone (teriparatide) on bone quality in osteoporosis. Clinical Calcium 2012 22 3 343 355
14. Reginster J. Y., Neuprez A., Strontium ranelate: a look back at its use for osteoporosis. Expert Opinion on Pharmacotherapy 2010 11 17 2915 2927 2-s2.0-78149427083 10.1517/14656566.2010.533170
15. Compston J., The use of combination therapy in the treatment of postmenopausal osteoporosis. Endocrine 2012 41 1 11 18
16. Zhang G., Qin L., Hung W. Y., Shi Y. Y., Leung P. C., Yeung H. Y., Leung K. S., Flavonoids derived from herbal Epimedium brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption. Bone 2006 38 6 818 825 2-s2.0-33749362515 10.1016/j.bone.2005.11.019 (Pubitemid 44498593)
17. Zhang D. W., Cheng Y., Wang N. L., Zhang J. C., Yang M. S., Yao X. S., Effects of total flavonoids and flavonol glycosides from Epimedium koreanum Nakai on the proliferation and differentiation of primary osteoblasts. Phytomedicine 2008 15 1-2 55 61 2-s2.0-37349035237 10.1016/j.phymed.2007.04.002 (Pubitemid 350297899)
18. Qian G., Zhang X., Lu L., Wu X., Li S., Meng J., Regulation of Cbfa1 expression by total flavonoids of Herba Epimedii. Endocrine Journal 2006 53 1 87 94 2-s2.0-33644993478 10.1507/endocrj.53.87
19. Songlin P., Ge Z., Yixin H., Xinluan W., Pingchung L., Kwoksui L., Ling Q., Epimedium-derived flavonoids promote osteoblastogenesis and suppress adipogenesis in bone marrow stromal cells while exerting an anabolic effect on osteoporotic bone. Bone 2009 45 3 534 544 2-s2.0-67949098855 10.1016/j.bone.2009.05.022
20. Zhang J. F., Li G., Chan C. Y., Meng C. L., Lin M. C. M., Chen Y. C., He M. L., Leung P. C., Kung H. F., Flavonoids of Herba Epimedii regulate osteogenesis of human mesenchymal stem cells through BMP and Wnt/ β -catenin signaling pathway. Molecular and Cellular Endocrinology 2010 314 1 70 74 2-s2.0-70350532232 10.1016/j.mce.2009.08.012
21. Nian H., Ma M. H., Nian S. S., Xu L. L., Antiosteoporotic activity of icariin in ovariectomized rats. Phytomedicine 2009 16 4 320 326 2-s2.0-62549091847 10.1016/j.phymed.2008.12.006
22. Hsieh T. P., Sheu S. Y., Sun J. S., Chen M. H., Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF- B regulated HIF-1 α and PGE2 synthesis. Phytomedicine 2011 18 2-3 176 185 2-s2.0-78651263812 10.1016/j.phymed.2010.04.003
23. Wong M. S., Mok S. K., Chen W. F., Lai W. P., Leung P. C., Wang X. L., Yao X. S., Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. British Journal of Pharmacology 2010 159 4 939 949 2-s2.0-77249175670 10.1111/j.1476-5381.2009.00593.x
24. Hsieh T. P., Sheu S. Y., Sun J. S., Chen M. H., Liu M. H., Icariin isolated from Epimedium pubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfa1 expression. Phytomedicine 2010 17 6 414 423 2-s2.0-77950021664 10.1016/j.phymed.2009.08.007
25. Choi H. J., Eun J. S., Park Y. R., Kim D. K., Li R., Moon W. S., Park J. M., Kim H. S., Cho N. P., Cho S. D., Soh Y., Ikarisoside A inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated RAW 264.7 cells via p38 kinase and nuclear factor-kappaB signaling pathways. European Journal of Pharmacology 2008 601 1-3 171 178 2-s2.0-56949083956 10.1016/j.ejphar.2008.09. 032
26. Choi H. J., Park Y. R., Nepal M., Choi B. Y., Cho N. P., Choi S. H., Heo S. R., Kim H. S., Yang M. S., Soh Y., Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-kappa B signaling pathways. European Journal of Pharmacology 2010 636 1-3 28 35 2-s2.0-77952672479 10.1016/j.ejphar.2010.03.023
27. Potter S. M., Baum J. A., Teng H., Stillman R. J., Shay N. F., Erdman J. W., Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. American Journal of Clinical Nutrition 1998 68 6 1375S 1379S 2-s2.0-0031772172 (Pubitemid 28550915)
28. Taku K., Melby M. K., Nishi N., Omori T., Kurzer M. S., Soy isoflavones for osteoporosis: an evidence-based approach. Maturitas 2011 70 4 333 338
29. Bitto A., Polito F., Burnett B., Levy R., Di Stefano V., Armbruster M. A., Marini H., Minutoli L., Altavilla D., Squadrito F., Protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats. Journal of Endocrinology 2009 201 3 321 328 2-s2.0-67849088714 10.1677/JOE-08-0552
30. Bitto A., Burnett B. P., Polito F., Levy R. M., Marini H., Stefano V. D., Irrera N., Armbruster M. A., Minutoli L., Altavilla D., Squadrito F., Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate. British Journal of Pharmacology 2009 156 8 1287 1295 2-s2.0-67849125875 10.1111/j.1476-5381. 2008.00100.x
31. Atteritano M., Mazzaferro S., Frisina A., Cannata M. L., Bitto A., D'Anna R., Squadrito F., MacRì I., Frisina N., Buemi M., Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women. Osteoporosis International 2009 20 11 1947 1954 2-s2.0-76449118908 10.1007/s00198-009-0883-4
32. Filipović B., Šošić-Jurjević B., Ajdžanović V., Brkić D., Manojlović-Stojanoski M., Milošević V., Sekulić M., Daidzein administration positively affects thyroid C cells and bone structure in orchidectomized middle-aged rats. Osteoporosis International 2010 21 9 1609 1616 2-s2.0-77956476409 10.1007/s00198-009-1092-x
33. Komrakova M., Sehmisch S., Tezval M., Schmelz U., Frauendorf H., Grueger T., Wessling T., Klein C., Birth M., Stuermer K. M., Stuermer E. K., Impact of 4-methylbenzylidene camphor, daidzein, and estrogen on intact and osteotomized bone in osteopenic rats. Journal of Endocrinology 2011 211 2 157 168
34. Wang D., Li F., Jiang Z., Osteoblastic proliferation stimulating activity of Psoralea corylifolia extracts and two of its flavonoids. Planta Medica 2001 67 8 748 749 2-s2.0-0034762493 (Pubitemid 33044484)
35. Xin D., Wang H., Yang J., Su Y. F., Fan G. W., Wang Y. F., Zhu Y., Gao X. M., Phytoestrogens from Psoralea corylifolia reveal estrogen receptor-subtype selectivity. Phytomedicine 2010 17 2 126 131 2-s2.0-73649107641 10.1016/j.phymed.2009.05.015
36. Park C. K., Lee Y., Chang E. J., Lee M. H., Yoon J. H., Ryu J. H., Kim H. H., Bavachalcone inhibits osteoclast differentiation through suppression of NFATc1 induction by RANKL. Biochemical Pharmacology 2008 75 11 2175 2182 2-s2.0-43049128125 10.1016/j.bcp.2008.03.007
37. Tang D. Z., Yang F., Yang Z., Huang J., Shi Q., Chen D., Wang Y. J., Psoralen stimulates osteoblast differentiation through activation of BMP signaling. Biochemical and Biophysical Research Communications 2011 405 2 256 261 2-s2.0-79651475048 10.1016/j.bbrc.2011.01.021
38. Wang X., Wu J., Chiba H., Yamada K., Ishimi Y., Puerariae radix prevents bone loss in castrated male mice. Metabolism 2005 54 11 1536 1541 2-s2.0-27344441175 10.1016/j.metabol.2005.05.022 (Pubitemid 41527026)
39. Wang X., Wu J., Chiba H., Umegaki K., Yamada K., Ishimi Y., Puerariae radix prevents bone loss in ovariectomized mice. Journal of Bone and Mineral Metabolism 2003 21 5 268 275 2-s2.0-0142182399 10.1007/s00774-003-0420-z (Pubitemid 38017703)
40. Woo J., Lau E., Ho S. C., Cheng F., Chan C., Chan A. S. Y., Haines C. J., Chan T. Y. K., Li M., Sham A., Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause. Menopause 2003 10 4 352 361 2-s2.0-0038164994 (Pubitemid 36870508)
41. Zhang Y., Zeng X., Zhang L., Zheng X., Stimulatory effect of puerarin on bone formation through activation of PI3K/Akt pathway in rat calvaria osteoblasts. Planta Medica 2007 73 4 341 347 2-s2.0-34250348437 10.1055/s-2007-967168 (Pubitemid 46910416)
42. Urasopon N., Hamada Y., Asaoka K., Cherdshewasart W., Malaivijitnond S., Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats. Maturitas 2007 56 3 322 331 2-s2.0-33846931509 10.1016/j.maturitas.2006.09.007 (Pubitemid 46241761)
43. Urasopon N., Hamada Y., Cherdshewasart W., Malaivijitnond S., Preventive effects of Pueraria mirifica on bone loss in ovariectomized rats. Maturitas 2008 59 2 137 148 2-s2.0-40249116220 10.1016/j.maturitas.2008.01.001
44. Circosta C., De Pasquale R., Palumbo D. R., Samperi S., Occhiuto F., Effects of isoflavones from red clover (Trifolium pratense) on skin changes induced by ovariectomy in rats. Phytotherapy Research 2006 20 12 1096 1099 2-s2.0-33845648029 10.1002/ptr.2017 (Pubitemid 44951717)
45. Beck V., Rohr U., Jungbauer A., Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy? Journal of Steroid Biochemistry and Molecular Biology 2005 94 5 499 518 2-s2.0-18144411278 10.1016/j.jsbmb.2004. 12.038 (Pubitemid 40616410)
46. Geller S., Studee L., Soy and red clover for mid-life and aging. Climacteric 2006 9 4 245 263 2-s2.0-33746596198 10.1080/13697130600736934 (Pubitemid 44147845)
47. Kawakita S., Marotta F., Naito Y., Gumaste U., Jain S., Tsuchiya J., Minelli E., Effect of an isoflavones-containing red clover preparation and alkaline supplementation on bone metabolism in ovariectomized rats. Clinical Interventions in Aging 2009 4 1 91 100 2-s2.0-66249123096
48. Kim H. K., Woo E. R., Lee H. W., Park H. R., Kim H. N., Jung Y. K., Choi J. Y., Chae S. W., Kim H. R., Chae H. J., The correlation of Salvia miltiorrhiza extract-induced regulation of osteoclastogenesis with the amount of components tanshinone I, tanshinone IIA, cryptotanshinone, and dihydrotanshinone. Immunopharmacology and Immunotoxicology 2008 30 2 347 364 2-s2.0-45849143699 10.1080/08923970801949133 (Pubitemid 351882917)
49. Chae H. J., Chae S. W., Yun D. H., Keum K. S., Yoo S. K., Kim H. R., Prevention of bone loss in ovariectomized rats: the effect of Salvia miltiorrhiza extracts. Immunopharmacology and Immunotoxicology 2004 26 1 135 144 2-s2.0-1942487828 10.1081/IPH-120029951 (Pubitemid 38495968)
50. Han B. K., Yang D., Ha H., Lee J. H., Kim H. N., Woo E. R., Lee S., Kim H. H., Zang H. L., Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1. Experimental and Molecular Medicine 2006 38 3 256 264 2-s2.0-33745817406 (Pubitemid 44033238)
51. Cui L., Liu Y. Y., Wu T., Ai C. M., Chen H. Q., Osteogenic effects of D(+) β -3, 4-dihydroxyphenyl lactic acid (salvianic acid A, SAA) on osteoblasts and bone marrow stromal cells of intact and prednisone-treated rats. Acta Pharmacologica Sinica 2009 30 3 321 332 2-s2.0-64849111963 10.1038/aps.2009.9
52. Cui L., Li T., Liu Y., Zhou L., Li P., Xu B., Huang L., Chen Y., Liu Y., Tian X., Jee W. S., Wu T., Salvianolic acid B prevents bone loss in prednisone-treated rats through stimulation osteogenensis and bone marrow angiogenesis. PLoS One 2012 7 4 e34647 10.1371/journal.pone.0034647
53. Sacco S. M., Jiang J. M. Y., Reza-López S., Ma D. W. L., Thompson L. U., Ward W. E., Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats. Menopause 2009 16 3 545 554 2-s2.0-67649884790 10.1097/gme.0b013e31818fc00a
54. Boulbaroud S., Mesfioui A., Arfaoui A., Ouichou A., El Hessni A., Preventive effects of flaxseed and sesame oil on bone loss in ovariectomized rats. Pakistan Journal of Biological Sciences 2008 11 13 1696 1701 2-s2.0-54049094819 10.3923/pjbs.2008.1696.1701
55. Kettler D. B., Can manipulation of the ratios of essential fatty acids slow the rapid rate of postmenopausal bone loss? Alternative Medicine Review 2001 6 1 61 77 2-s2.0-0035119958 (Pubitemid 32194961)
56. Arjmandi B. H., The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency. Journal of the American College of Nutrition 2001 20 5, supplement 398S 402S 2-s2.0-0034799329 (Pubitemid 32948020)
57. Jeong J. C., Lee J. W., Yoon C. H., Kim H. M., Kim C. H., Drynariae Rhizoma promotes osteoblast differentiation and mineralization in MC3T3-E1 cells through regulation of bone morphogenetic protein-2, alkaline phosphatase, type I collagen and collagenase-1. Toxicology in vitro 2004 18 6 829 834 2-s2.0-4744351420 10.1016/j.tiv.2004.05.002 (Pubitemid 39311895)
58. Wang X. L., Wang N. L., Zhang Y., Gao H., Pang W. Y., Wong M. S., Zhang G., Qin L., Yao X. S., Effects of eleven flavonoids from the osteoprotective fraction of Drynaria fortunei (Kunze) J. Sm. on osteoblastic proliferation using an osteoblast-like cell line. Chemical and Pharmaceutical Bulletin 2008 56 1 46 51 2-s2.0-38049115718 10.1248/cpb.56.46
59. Wang X., Zhen L., Zhang G., Wong M. S., Qin L., Yao X., Osteogenic effects of flavonoid aglycones from an osteoprotective fraction of Drynaria fortunei-an in vitro efficacy study. Phytomedicine 2011 18 10 868 872 2-s2.0-79959921754 10.1016/j.phymed.2011.01.022
60. Eun J. C., Won J. L., Sung H. C., Sang W. C., Proliferative effects of flavan-3-ols and propelargonidins from rhizomes of Drynaria fortunei on MCF-7 and osteoblastic cells. Archives of Pharmacal Research 2003 26 8 620 630 2-s2.0-2342577021 (Pubitemid 43080194)
61. Guo D., Wang J., Wang X., Luo H., Zhang H., Cao D., Chen L., Huang N., Double directional adjusting estrogenic effect of naringin from Rhizoma drynariae (Gusuibu). Journal of Ethnopharmacology 2011 138 451 457
62. Seidlová-Wuttke D., Jarry H., Becker T., Christoffel V., Wuttke W., Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus. Maturitas 2003 44 supplement S39 S50 2-s2.0-0037436792 10.1016/S0378-5122(02)00347-X (Pubitemid 36263034)
63. Wuttke W., Seidlová-Wuttke D., Gorkow C., The Cimicifuga preparation BNO 1055 versus conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003 44 supplement S67 S77 2-s2.0-0037436823 10.1016/S0378-5122(02) 00350-X (Pubitemid 36263037)
64. Choi E. M., Deoxyactein stimulates osteoblast function and inhibits bone-resorbing mediators in MC3T3-E1 cells. Journal of Applied Toxicology. In press 10.1002/jat.1733
65. Viereck V., Gründker C., Friess S. C., Frosch K. H., Raddatz D., Schoppet M., Nisslein T., Emons G., Hofbauer L. C., Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts. Journal of Bone and Mineral Research 2005 20 11 2036 2043 2-s2.0-27444438388 10.1359/JBMR.050716 (Pubitemid 41532789)
66. Kolios L., Schumann J., Sehmisch S., Rack T., Tezval M., Seidlova-Wuttke D., Frosch K. H., Stuermer K. M., Stuermer E. K., Effects of black cohosh (Cimicifuga racemosa) and estrogen on metaphyseal fracture healing in the early stage of osteoporosis in ovariectomized rats. Planta Medica 2010 76 9 850 857 2-s2.0-77953836705 10.1055/s-0029-1240798
67. Seo B. I., Ku S. K., Cha E. M., Park J. H., Kim J. D., Choi H. Y., Lee H. S., Effect of Mornidae radix extracts on experimental osteoporosis in sciatic neurectomized mice. Phytotherapy Research 2005 19 3 231 238 2-s2.0-20444441921 10.1002/ptr.1683 (Pubitemid 40827648)
68. Li N., Qin L. P., Han T., Wu Y. B., Zhang Q. Y., Zhang H., Inhibitory effects of Morinda officinalis extract on bone loss in ovariectomized rats. Molecules 2009 14 6 2049 2061 2-s2.0-67649886666 10.3390/molecules14062049
69. MengYong Z., CaiJiao W., HuSheng Z., XianWu P., JianMin F., Protective effect of polysaccharides from Morinda officinalis on bone loss in ovariectomized rats. International Journal of Biological Macromolecules 2008 43 3 276 278 2-s2.0-49749123819 10.1016/j.ijbiomac.2008.06.008
70. Wu Y. B., Zheng C. J., Qin L. P., Sun L. N., Han T., Jiao L., Zhang Q. Y., Wu J. Z., Antiosteoporotic activity of anthraquinones from Morinda officinalis on osteoblasts and osteoclasts. Molecules 2009 14 1 573 583 2-s2.0-59349083558 10.3390/molecules14010573
71. Bao L., Qin L., Liu L., Wu Y., Han T., Xue L., Zhang Q., Anthraquinone compounds from Morinda officinalis inhibit osteoclastic bone resorption in vitro. Chemico-Biological Interactions 2011 194 2-3 97 105
72. Choi E. M., Kaempferol protects MC3T3-E1 cells through antioxidant effect and regulation of mitochondrial function. Food and Chemical Toxicology 2011 49 8 1800 1805
73. Liang W., Luo Z., Ge S., Li M., Du J., Yang M., Yan M., Ye Z., Luo Z., Oral administration of quercetin inhibits bone loss in rat model of diabetic osteopenia. European Journal of Pharmacology 2011 670 1 317 324
74. Inoue J., Choi J. M., Yoshidomi T., Yashiro T., Sato R., Quercetin enhances VDR activity, leading to stimulation of its target gene expression in Caco-2 Cells. Journal of Nutritional Science and Vitaminology 2010 56 5 326 330 2-s2.0-78651482825 10.3177/jnsv.56.326
75. Zhang P., Dai K. R., Yan S. G., Yan W. Q., Zhang C., Chen D. Q., Xu B., Xu Z. W., Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell. European Journal of Pharmacology 2009 607 1-3 11 15
76. Wu J. B., Fong Y. C., Tsai H. Y., Chen Y. F., Tsuzuki M., Tang C. H., Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. European Journal of Pharmacology 2008 588 2-3 333 341 2-s2.0-44649083061 10.1016/j.ejphar.2008.04.030
77. Ang E. S., Yang X., Chen H., Liu Q., Zheng M. H., Xu J., Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-kappaB and ERK activation. FEBS Letters 2011 585 17 2755 2762
78. Horcajada M. N., Habauzit V., Trzeciakiewicz A., Morand C., Gil-Izquierdo A., Mardon J., Lebecque P., Davicco M. J., Chee W. S. S., Coxam V., Offord E., Hesperidin inhibits ovariectomized-induced osteopenia and shows differential effects on bone mass and strength in young and adult intact rats. Journal of Applied Physiology 2008 104 3 648 654 2-s2.0-41549146625 10.1152/japplphysiol. 00441.2007 (Pubitemid 351468792)
79. Kim Y. H., Lee Y. S., Choi E. M., Linarin isolated from Buddleja officinalis prevents hydrogen peroxide-induced dysfunction in osteoblastic MC3T3-E1 cells. Cellular Immunology 2011 268 2 112 116 2-s2.0-79954418842 10.1016/j.cellimm.2011.02.002
80. Horcajada-Molteni M. N., Crespy V., Coxam V., Davicco M. J., Remesy C., Barlet J. P., Rutin inhibits ovariectomy-induced osteopenia in rats. Journal of Bone and Mineral Research 2000 15 11 2251 2258 2-s2.0-0033783159
81. Choi E. M., Hwang J. K., Effects of (+)-catechin on the function of osteoblastic cells. Biological and Pharmaceutical Bulletin 2003 26 4 523 526 2-s2.0-0642286444
82. Harada S., Tominari T., Matsumoto C., Hirata M., Takita M., Inada M., Miyaura C., Nobiletin, a polymethoxy flavonoid, suppresses bone resorption by inhibiting NF B-dependent prostaglandin E synthesis in osteoblasts and prevents bone loss due to estrogen deficiency. Journal of Pharmacological Sciences 2011 115 1 89 93 2-s2.0-79952373608 10.1254/jphs.10193SC
83. Kim T. H., Jung J. W., Ha B. G., Hong J. M., Park E. K., Kim H. J., Kim S. Y., The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss. Journal of Nutritional Biochemistry 2011 22 1 8 15 2-s2.0-78649931136 10.1016/j.jnutbio.2009.11.002
84. Kim M. H., Ryu S. Y., Bae M. A., Choi J. S., Min Y. K., Kim S. H., Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis. Food and Chemical Toxicology 2008 46 11 3375 3382 2-s2.0-54449086557 10.1016/j.fct.2008.08.016
85. Guo A. J., Choi R. C., Cheung A. W., Chen V. P., Xu S. L., Dong T. T., Chen J. J., Tsim K. W., Baicalin, a flavone, induces the differentiation of cultured osteoblasts: an action via the Wnt/beta-catenin signaling pathway. Journal of Biological Chemistry 2011 286 32 27882 27893
86. Jeong H. M., Han E. H., Jin Y. H., Choi Y. H., Lee K. Y., Jeong H. G., Xanthohumol from the hop plant stimulates osteoblast differentiation by RUNX2 activation. Biochemical and Biophysical Research Communications 2011 409 1 82 89 2-s2.0-79956221794 10.1016/j.bbrc.2011.04.113
87. Zhang Q., Qin L., He W., Van Puyvelde L., Maes D., Adams A., Zheng H., De Kimpe N., Coumarins from Cnidium monnieri and their antiosteoporotic activity. Planta Medica 2007 73 1 13 19 2-s2.0-33847794096 10.1055/s-2006-951724 (Pubitemid 46909846)
88. Choi E. M., Honokiol isolated from Magnolia officinalis stimulates osteoblast function and inhibits the release of bone-resorbing mediators. International Immunopharmacology 2011 11 10 1541 1545 2-s2.0-79957876195 10.1016/j.intimp.2011.05.011
89. Choi E. M., Honokiol protects osteoblastic MC3T3-E1 cells against antimycin A-induced cytotoxicity. Inflammation Research 2011 60 11 1005 1012 2-s2.0-79960678572 10.1007/s00011-011-0360-3
90. Yin J., Tezuka Y., Subehan, Shi L., Nobukawa M., Nobukawa T., Kadota S., In vivo anti-osteoporotic activity of isotaxiresinol, a lignan from wood of Taxus yunnanensis. Phytomedicine 2006 13 1-2 37 42 2-s2.0-29144530335 10.1016/j.phymed.2004.06.017 (Pubitemid 41797589)
91. Choi E. M., Magnolol protects osteoblastic MC3T3-E1 cells against antimycin A-induced cytotoxicity through activation of mitochondrial function. Inflammation 2012 35 3 1204 1212
92. Song L. H., Pan W., Yu Y. H., Quarles L. D., Zhou H. H., Xiao Z. S., Resveratrol prevents CsA inhibition of proliferation and osteoblastic differentiation of mouse bone marrow-derived mesenchymal stem cells through an ER/NO/cGMP pathway. Toxicology in Vitro 2006 20 6 915 922 2-s2.0-33745212659 10.1016/j.tiv.2006.01.016
93. He X., Andersson G., Lindgren U., Li Y., Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production. Biochemical and Biophysical Research Communications 2010 401 3 356 362 2-s2.0-77958153014 10.1016/j.bbrc.2010.09.053
94. Shakibaei M., Buhrmann C., Mobasheri A., Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF- B ligand (RANKL) activation of NF- B Signaling and inhibit osteoclastogenesis in bone-derived cells. Journal of Biological Chemistry 2011 286 13 11492 11505 2-s2.0-79953191835 10.1074/jbc.M110.198713
95. Tseng P. C., Hou S. M., Chen R. J., Peng H. W., Hsieh C. F., Kuo M. L., Yen M. L., Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis. Journal of Bone and Mineral Research 2011 26 10 2552 2563
96. Yang M. W., Wang T. H., Yan P. P., Chu L. W., Yu J., Gao Z. D., Li Y. Z., Guo B. L., Curcumin improves bone microarchitecture and enhances mineral density in APP/PS1 transgenic mice. Phytomedicine 2011 18 2-3 205 213 2-s2.0-78651292213 10.1016/j.phymed.2010.05.011
97. French D. L., Muir J. M., Webber C. E., The ovariectomized, mature rat model of postmenopausal osteoporosis: an assessment of the bone sparing effects of curcumin. Phytomedicine 2008 15 12 1069 1078 2-s2.0-56249139340 10.1016/j.phymed.2008.06.007
98. Kim W. K., Ke K., Sul O. J., Kim H. J., Kim S. H., Lee M. H., Kim H. J., Kim S. Y., Chung H. T., Choi H. S., Curcumin protects against ovariectomy-induced bone loss and decreases osteoclastogenesis. Journal of Cellular Biochemistry 2011 112 11 3159 3166
99. Kamon M., Zhao R., Sakamoto K., Green tea polyphenol (-)-epigallocatechin gallate suppressed the differentiation of murine osteoblastic MC3T3-E1 cells. Cell Biology International 2010 34 1 109 116 2-s2.0-77951930977 10.1042/CBI20090011
100. Shen C. L., Wang P., Guerrieri J., Yeh J. K., Wang J. S., Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporosis International 2008 19 7 979 990 2-s2.0-44649110136 10.1007/s00198-007-0527-5
101. Yonezawa T., Hasegawa S. I., Asai M., Ninomiya T., Sasaki T., Cha B. Y., Teruya T., Ozawa H., Yagasaki K., Nagai K., Woo J. T., Harmine, a β -carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo. European Journal of Pharmacology 2011 650 2-3 511 518 2-s2.0-78651087056 10.1016/j.ejphar.2010.10.048
102. Lee J. W., Iwahashi A., Hasegawa S. I., Yonezawa T., Jeon W. B., Cha B. Y., Nagai K., Woo J. T., Coptisine inhibits RANKL-induced NF- B phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells. Journal of Natural Medicines 2011 66 1 8 16 2-s2.0-79957955809 10.1007/s11418-011-0537-7
103. Lee J. W., Mase N., Yonezawa T., Seo H. J., Jeon W. B., Cha B. Y., Nagai K., Woo J. T., Palmatine attenuates osteoclast differentiation and function through inhibition of receptor activator of nuclear factor- B ligand expression in osteoblast cells. Biological and Pharmaceutical Bulletin 2010 33 10 1733 1739 2-s2.0-77957991958
104. Li H., Miyahara T., Tezuka Y., Le Tran Q., Seto H., Kadota S., Effect of berberine on bone mineral density in SAMP6 as a senile osteoporosis model. Biological and Pharmaceutical Bulletin 2003 26 1 110 111 2-s2.0-0038721145 10.1248/bpb.26.110 (Pubitemid 39663656)
105. Hyun W. L., Jung H. S., Kim H. N., A Y. K., So Y. P., Chan S. S., Choi J. Y., Jae B. K., Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK. Journal of Bone and Mineral Research 2008 23 8 1227 1237 2-s2.0-47949108989 10.1359/jbmr.080325 (Pubitemid 352042688)
106. Jiao L., Cao D. P., Qin L. P., Han T., Zhang Q. Y., Zhu Z., Yan F., Antiosteoporotic activity of phenolic compounds from Curculigo orchioides. Phytomedicine 2009 16 9 874 881 2-s2.0-67650562564 10.1016/j.phymed.2009.01.005
107. Wang Y., Zhao L., Wang Y., Xu J. L., Nie Y., Guo Y. H., Tong Y. T., Qin L. P., Zhang Q. Y., Curculigoside isolated from Curculigo orchioides prevents hydrogen peroxide-induced dysfunction and oxidative damage in calvarial osteoblasts. Acta Biochimica et Biophysica Sinica 2012 44 5 431 441
108. Niu Y., Li Y., Huang H., Kong X., Zhang R., Liu L., Sun Y., Wang T., Mei Q., Asperosaponin VI, a saponin component from Dipsacus asper wall, induces osteoblast differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway. Phytotherapy Research 2011 25 11 1700 1706 2-s2.0-79953255542 10.1002/ptr.3414
109. Wisutsitthiwong C., Buranaruk C., Pudhom K., Palaga T., The plant limonoid 7-oxo-deacetoxygedunin inhibits RANKL-induced osteoclastogenesis by suppressing activation of the NF-kappaB and MAPK pathways. Biochemical and Biophysical Research Communications 2011 415 2 361 366
110. Sung B., Murakami A., Oyajobi B. O., Aggarwal B. B., Zerumbone abolishes RaNKL-induced NF- B activation, inhibits osteoclastogenesis, and suppresses human breast cancer-induced bone loss in athymic nude mice. Cancer Research 2009 69 4 1477 1484 2-s2.0-60549113238 10.1158/0008-5472.CAN-08-3249
111. Lee Y. S., Choi E. M., Costunolide stimulates the function of osteoblastic MC3T3-E1 cells. International Immunopharmacology 2011 11 6 712 718 2-s2.0-79955802958 10.1016/j.intimp.2011.01.018
112. Sahni S., Hannan M. T., Blumberg J., Cupples L. A., Kiel D. P., Tucker K. L., Protective effect of total carotenoid and lycopene intake on the risk of hip fracture: a 17-year follow-up from the Framingham osteoporosis atudy. Journal of Bone and Mineral Research 2009 24 6 1086 1094 2-s2.0-66349125617 10.1359/jbmr.090102
113. MacKinnon E. S., Rao A. V., Josse R. G., Rao L. G., Supplementation with the antioxidant lycopene significantly decreases oxidative stress parameters and the bone resorption marker N-telopeptide of type i collagen in postmenopausal women. Osteoporosis International 2011 22 4 1091 1101 2-s2.0-79953329381 10.1007/s00198-010-1308-0
114. Lee J. W., Kobayashi Y., Nakamichi Y., Udagawa N., Takahashi N., Im N. K., Seo H. J., Jeon W. B., Yonezawa T., Cha B. Y., Woo J. T., Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice. Biochemical Pharmacology 2010 80 3 352 361 2-s2.0-77953479142 10.1016/j.bcp.2010.04.014
115. Li C., Yang Z., Li Z., Ma Y., Zhang L., Zheng C., Qiu W., Wu X., Wang X., Li H., Tang J., Qian M., Li D., Wang P., Luo J., Liu M., Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF- B and MAPK signaling pathways. Journal of Bone and Mineral Research 2011 26 3 644 656 2-s2.0-79951821134 10.1002/jbmr.242
116. Raisz L. G., The osteoporosis revolution. Annals of Internal Medicine 1997 126 6 458 462 2-s2.0-0031043491 (Pubitemid 27114475)
117. O'Loughlin P. D., Morris H. A., Oestrogen deficiency impairs intestinal calcium absorption in the rat. Journal of Physiology 1998 511 1 313 322 2-s2.0-0032529008 10.1111/j.1469-7793.1998.313bi.x (Pubitemid 28421333)
118. Lean J. M., Davies J. T., Fuller K., Jagger C. J., Kirstein B., Partington G. A., Urry Z. L., Chambers T. J., A crucial role for thiol antioxidants in estrogen-deficiency bone loss. Journal of Clinical Investigation 2003 112 6 915 923 2-s2.0-0142186681 10.1172/JCI200318859 (Pubitemid 38063749)
119. Puel C., Quintin A., Agalias A., Mathey J., Obled C., Mazur A., Davicco M. J., Lebecque P., Skaltsounis A. L., Coxam V., Olive oil and its main phenolic micronutrient (oleuropein) prevent inflammation-induced bone loss in the ovariectomised rat. British Journal of Nutrition 2004 92 1 119 127 2-s2.0-3142621283 10.1079/BJN20041181 (Pubitemid 38961280)
120. Xu M., Qi C., Deng B., Deng P. X., Mo C. W., Phytotherapy versus hormonal therapy for postmenopausal bone loss: a meta-analysis. Osteoporosis International 2009 20 4 519 526 2-s2.0-62149108645 10.1007/s00198-008-0724-x
121. Resmini G., Iolascon G., New insights into the teriparatide. Aging Clinical and Experimental Research 2011 23 2, supplement 30 32
122. Man S. C., Chan K. W., Lu J. H., Sundara S., Durairajan K., Liu L. F., Li M., Systematic review on the efficacy and safety of herbal medicines for vascular dementia. Evidence-Based Complementary and Alternative Medicine 2012 2012 22 426215 10.1155/2012/426215
123. He C. C., Hui R. R., Tezuka Y., Kadota S., Li J. X., Osteoprotective effect of extract from Achyranthes bidentata in ovariectomized rats. Journal of Ethnopharmacology 2010 127 2 229 234 2-s2.0-73749084306 10.1016/j.jep.2009.11. 016
124. Zhang R., Hu S. J., Li C., Zhang F., Gan H. Q., Mei Q. B., Achyranthes bidentata root extract prevent OVX-induced osteoporosis in rats. Journal of Ethnopharmacology 2010 139 1 12 18
125. Cao D. P., Zheng Y. N., Qin L. P., Han T., Zhang H., Rahman K., Zhang Q. Y., Curculigo orchioides, a traditional Chinese medicinal plant, prevents bone loss in ovariectomized rats. Maturitas 2008 59 4 373 380 2-s2.0-44349104649 10.1016/j.maturitas.2008.03.010
126. Liao J. M., Zhu Q. A., Lu H. J., Li Q. N., Wu T., Huang L. F., Effects of total coumarins of Cnidium monnieri on bone density and biomechanics of glucocorticoids-induced osteoporosis in rats. Acta Pharmacologica Sinica 1997 18 6 519 521 2-s2.0-0030736641 (Pubitemid 27473887)
127. Li C. Y., Wu T., Li Q. N., Liang N. C., Huang L. F., Cui L., Zhuang H. Q., Cai C., Mo L. E., Effects of fructus Cnidii coumarins compared with nilestriol on osteoporosis in ovariectomized rats. Zhongguo Yao Li Xue Bao 1997 18 3 286 288 2-s2.0-0031011772 (Pubitemid 27228798)
128. Shirke S. S., Jadhav S. R., Jagtap A. G., Methanolic extract of cuminum cyminum inhibits ovariectomy-induced bone loss in rats. Experimental Biology and Medicine 2008 233 11 1403 1410 2-s2.0-58249084395 10.3181/0803-RM-93
129. Ferretti M., Bertoni L., Cavani F., Zavatti M., Resca E., Carnevale G., Benelli A., Zanoli P., Palumbo C., Influence of ferutinin on bone metabolism in ovariectomized rats. II: role in recovering osteoporosis. Journal of Anatomy 2010 217 1 48 56 2-s2.0-77954116922 10.1111/j.1469-7580.2010.01242.x
130. Yang Q., Populo S. M., Zhang J., Yang G., Kodama H., Effect of Angelica sinensis on the proliferation of human bone cells. Clinica Chimica Acta 2002 324 1-2 89 97 2-s2.0-0036774090 10.1016/S0009-8981(02)00210-3 (Pubitemid 35245499)
131. Shen Y., Li Y. Q., Li S. P., Ma L., Ding L. J., Ji H., Alleviation of ovariectomy-induced osteoporosis in rats by Panax notoginseng saponins. Journal of Natural Medicines 2010 64 3 336 345 2-s2.0-77953621304 10.1007/s11418-010- 0416-7
132. Li X. D., Wang J. S., Chang B., Chen B., Guo C., Hou G. Q., Huang D. Y., Du S. X., Panax notoginseng saponins promotes proliferation and osteogenic differentiation of rat bone marrow stromal cells. Journal of Ethnopharmacology 2011 134 2 268 274 2-s2.0-79952697425 10.1016/j.jep.2010.11.075
133. Hwang Y. C., Jeong I. K., Ahn K. J., Chung H. Y., The effects of Acanthopanax senticosus extract on bone turnover and bone mineral density in Korean postmenopausal women. Journal of Bone and Mineral Metabolism 2009 27 5 584 590 2-s2.0-68949163531 10.1007/s00774-009-0093-3
134. Yogesh H. S., Chandrashekhar V. M., Katti H. R., Ganapaty S., Raghavendra H. L., Gowda G. K., Goplakhrishna B., Anti-osteoporotic activity of aqueous-methanol extract of Berberis aristata in ovariectomized rats. Journal of Ethnopharmacology 2011 134 2 334 338 2-s2.0-79952700565 10.1016/j.jep.2010.12. 013
135. Pattell V. M., Berberis Aristata Plants Extracts for Treating Osteoporosis and the Extraction Process Thereof 2008 Avestha Gengraine Technologies PVT. http://patentscope.wipo.int/search/en/WO2008007215
136. Zhang Y., Yu L., Ao M., Jin W., Effect of ethanol extract of Lepidium meyenii Walp. on osteoporosis in ovariectomized rat. Journal of Ethnopharmacology 2006 105 1-2 274 279 2-s2.0-33645325111 10.1016/j.jep.2005.12. 013
137. Gonzales G. F., Ethnobiology and ethnopharmacology of Lepidium meyenii (Maca), a plant from the Peruvian Highlands. Evidence-Based Complementary and Alternative Medicine 2012 2012 10 10.1155/2012/193496 193496
138. Jeong H. M., Han E. H., Jin Y. H., Hwang Y. P., Kim H. G., Park B. H., Kim J. Y., Chung Y. C., Lee K. Y., Jeong H. G., Saponins from the roots of Platycodon grandiflorum stimulate osteoblast differentiation via p38 MAPK- and ERK-dependent RUNX2 activation. Food and Chemical Toxicology 2010 48 12 3362 3368 2-s2.0-78049439172 10.1016/j.fct.2010.09.005
139. Zhang Y., Li Q., Wan H. Y., Xiao H. H., Lai W. P., Yao X. S., Wong M. S., Study of the mechanisms by which Sambucus williamsii HANCE extract exert protective effects against ovariectomy-induced osteoporosis in vivo. Osteoporosis International 2011 22 2 703 709 2-s2.0-78651511545 10.1007/s00198-010-1240-3
140. Kim H. J., Bae Y. C., Park R. W., Choi S. W., Cho S. H., Choi Y. S., Lee W. J., Bone-protecting effect of safflower seeds in ovariectomized rats. Calcified Tissue International 2002 71 1 88 94 2-s2.0-0036653633 10.1007/s00223-001-1080-4 (Pubitemid 36934781)
141. Lee Y. S., Choi C. W., Kim J. J., Ganapathi A., Udayakumar R., Kim S. C., Determination of mineral content in methanolic safflower (Carthamus tinctorius L.) seed extract and its effect on osteoblast markers. International Journal of Molecular Sciences 2009 10 1 292 305 2-s2.0-59649109468 10.3390/ijms10010292
142. Kim J. L., Kang S. W., Kang M. K., Gong J. H., Lee E. S., Han S. J., Kang Y. H., Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts. Journal of Cellular Biochemistry 2012 113 1 247 259
143. El-Shitany N. A., Hegazy S., El-desoky K., Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats. Phytomedicine 2010 17 2 116 125 2-s2.0-73449128972 10.1016/j.phymed.2009.05.012
144. Annie S., Prabhu R. G., Malini S., Activity of Wedelia calendulacea Less. in post-menopausal osteoporosis. Phytomedicine 2006 13 1-2 43 48 2-s2.0-29144442234 10.1016/j.phymed.2004.01.011 (Pubitemid 41797590)
145. Ding Y., Liang C., Yang S. Y., Ra J. C., Choi E. M., Kim J. A., Ho Kim Y., Phenolic compounds from Artemisia iwayomogi and their effects on osteoblastic MC3T3-E1 cells. Biological and Pharmaceutical Bulletin 2010 33 8 1448 1453 2-s2.0-77956131069 10.1248/bpb.33.1448
146. Yang L., Chen Q., Wang F., Zhang G., Antiosteoporotic compounds from seeds of Cuscuta chinensis. Journal of Ethnopharmacology 2011 135 2 553 560 2-s2.0-79955685285 10.1016/j.jep.2011.03.056
147. Yang H. M., Shin H. K., Kang Y. H., Kim J. K., Cuscuta chinensis extract promotes osteoblast differentiation and mineralization in human osteoblast-like MG-63 cells. Journal of Medicinal Food 2009 12 1 85 92 2-s2.0-64949104330 10.1089/jmf.2007.0665
148. Ko Y. J., Wu J. B., Ho H. Y., Lin W. C., Antiosteoporotic activity of Davallia formosana. Journal of Ethnopharmacology 2012 139 558 565
149. Zhao X., Wu Z. X., Zhang Y., Yan Y. B., He Q., Cao P. C., Lei W., Anti-osteoporosis activity of Cibotium barometz extract on ovariectomy-induced bone loss in rats. Journal of Ethnopharmacology 2011 137 3 1083 1088
150. Peng K. Y., Horng L. Y., Sung H. C., Huang H. C., Wu R. T., Antiosteoporotic activity of Dioscorea alata L. cv. phyto through driving mesenchymal stem cells differentiation for bone formation. Evidence-Based Complementary and Alternative Medicine 2011 2011 12 712892 10.1155/2011/712892
151. Yin J., Tezuka Y., Kouda K., Le Tran Q., Miyahara T., Chen Y., Kadota S., Antiosteoporotic activity of the water extract of Dioscorea spongiosa. Biological and Pharmaceutical Bulletin 2004 27 4 583 586 2-s2.0-16544365677 10.1248/bpb.27.583 (Pubitemid 41701851)
152. Yin J., Tezuka Y., Kouda K., Le Tran Q., Miyahara T., Chen Y., Kadota S., In vivo antiosteoporotic activity of a fraction of Dioscorea spongiosa and its constituent, 22-O-methylprotodioscin. Planta Medica 2004 70 3 220 226 2-s2.0-1842484342 10.1055/s-2004-815538 (Pubitemid 38445187)
153. Liu Z. G., Zhang R., Li C., Ma X., Liu L., Wang J. P., Mei Q. B., The osteoprotective effect of Radix Dipsaci extract in ovariectomized rats. Journal of Ethnopharmacology 2009 123 1 74 81 2-s2.0-64249122620 10.1016/j.jep.2009.02. 025
154. Devareddy L., Hooshmand S., Collins J. K., Lucas E. A., Chai S. C., Arjmandi B. H., Blueberry prevents bone loss in ovariectomized rat model of postmenopausal osteoporosis. Journal of Nutritional Biochemistry 2008 19 10 694 699 2-s2.0-50949104228 10.1016/j.jnutbio.2007.09.004
155. Ha H., Ho J., Shin S., Kim H., Koo S., Kim I. H., Kim C., Effects of Eucommiae cortex on osteoblast-like cell proliferation and osteoclast inhibition. Archives of Pharmacal Research 2003 26 11 929 936 2-s2.0-3042601244
156. Zhang R., Liu Z. G., Li C., Hu S. J., Liu L., Wang J. P., Mei Q. B., Du-Zhong (Eucommia ulmoides Oliv.) cortex extract prevent OVX-induced osteoporosis in rats. Bone 2009 45 3 553 559 2-s2.0-67949120224 10.1016/j.bone.2008.08.127
157. Li Y., Wang M. J., Li S., Zhang Y. M., Zhao Y., Xie R. M., Sun W. J., Effect of total glycosides from Eucommia ulmoides seed on bone microarchitecture in rats. Phytotherapy Research 2011 25 12 1895 1897 2-s2.0-79958290776 10.1002/ptr.3543
158. Penolazzi L., Lampronti I., Borgatti M., Khan M. T. H., Zennaro M., Piva R., Gambari R., Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis. BMC Complementary and Alternative Medicine 2008 8 article no. 59 59 71 2-s2.0-57049122841 10.1186/1472-6882-8-59
159. Zhang Y., Li Q., Li X., Wan H. Y., Wong M. S., Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption. British Journal of Nutrition 2010 104 7 965 971 2-s2.0-77957921074 10.1017/S0007114510001789
160. Zhang Y., Li X. L., Lai W. P., Chen B., Chow H. K., Wu C. F., Wang N. L., Yao X. S., Wong M. S., Anti-osteoporotic effect of Erythrina variegata L. in ovariectomized rats. Journal of Ethnopharmacology 2007 109 1 165 169 2-s2.0-33751428397 10.1016/j.jep.2006.07.005 (Pubitemid 44821673)
161. Dontas I., Halabalaki M., Moutsatsou P., Mitakou S., Papoutsi Z., Khaldi L., Galanos A., Lyritis G. P., Protective effect of plant extract from Onobrychis ebenoides on ovariectomy-induced bone loss in rats. Maturitas 2006 53 2 234 242 2-s2.0-29244487579 10.1016/j.maturitas.2005.05.007 (Pubitemid 41820517)
162. Halabalaki M., Alexi X., Aligiannis N., Lambrinidis G., Pratsinis H., Florentin I., Mitakou S., Mikros E., Skaltsounis A. L., Alexis M. N., Estrogenic activity of isoflavonoids from Onobrychis ebenoides. Planta Medica 2006 72 6 488 493 2-s2.0-33744938204 10.1055/s-2005-916261 (Pubitemid 43844674)
163. Papoutsi Z., Kassi E., Papaevangeliou D., Pratsinis H., Zoumpourlis V., Halabalaki M., Mitakou S., Kalofoutis A., Moutsatsou P., Plant 2-arylobenzofurans demonstrate a selective estrogen receptor modulator profile. Steroids 2004 69 11-12 727 734 2-s2.0-9644273990 10.1016/j.steroids.2004.07.005 (Pubitemid 39576716)
164. Kim J., Um S. J., Woo J., Kim J. Y., Kim H. A., Jang K. H., Kang S. A., Lim B. O., Kang I., Choue R. W., Cho Y., Comparative effect of seeds of Rhynchosia volubilis and soybean on MG-63 human osteoblastic cell proliferation and estrogenicity. Life Sciences 2005 78 1 30 40 2-s2.0-27444447906 10.1016/j.lfs.2005.03.039 (Pubitemid 41528795)
165. Joo S. S., Won T. J., Kang H. C., Lee D. I., Isoflavones extracted from Sophorae fructus upregulate IGF-I and TGF- β and inhibit osteoclastogenesis in rat born marrow cells. Archives of Pharmacal Research 2004 27 1 99 105 2-s2.0-6944228180
166. Joo S. S., Kang H. C., Lee M. W., Choi Y. W., Lee D. I., Inhibition of IL-1beta and IL-6 in osteoblast-like cell by isoflavones extracted from Sophorae fructus. Archives of Pharmacal Research 2003 26 12 1029 1035 2-s2.0-4143069009
167. Pandey R., Gautam A. K., Bhargavan B., Trivedi R., Swarnkar G., Nagar G. K., Yadav D. K., Kumar M., Rawat P., Manickavasagam L., Kumar A., Maurya R., Goel A., Jain G. K., Chattopadhyay N., Singh D., Total extract and standardized fraction from the stem bark of Butea monosperma have osteoprotective action: evidence for the nonestrogenic osteogenic effect of the standardized fraction. Menopause 2010 17 3 602 610 2-s2.0-77952275063 10.1097/gme.0b013e3181d0f7f0
168. Shirke S. S., Jadhav S. R., Jagtap A. G., Osteoprotective effect of Phaseolus vulgaris L in ovariectomy-induced osteopenia in rats. Menopause 2009 16 3 589 596 2-s2.0-67649873336 10.1097/gme.0b013e31818e64c4
169. Lucinda L. M. F., Vieira B. J., Oliveira T. T., Sá R. C. S., Peters V. M., Reis J. E. P., Guerra M. O., Evidences of osteoporosis improvement in Wistar rats treated with Ginkgo biloba extract: a histomorphometric study of mandible and femur. Fitoterapia 2010 81 8 982 987 2-s2.0-78549253111 10.1016/j.fitote.2010.06.014
170. Oh S. M., Kim H. R., Chung K. H., Effects of Ginkgo biloba on in vitro osteoblast cells and ovariectomized rat osteoclast cells. Archives of Pharmacal Research 2008 31 2 216 224 2-s2.0-42949128211 10.1007/s12272-001-1144-z
171. Papoutsi Z., Kassi E., Chinou I., Halabalaki M., Skaltsounis L. A., Moutsatsou P., Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. British Journal of Nutrition 2008 99 4 715 722 2-s2.0-40449114156 10.1017/S0007114507837421 (Pubitemid 351351624)
172. Ono Y., Fukaya Y., Imai S., Yamakuni T., Beneficial effects of Ajuga decumbens on osteoporosis and arthritis. Biological and Pharmaceutical Bulletin 2008 31 6 1199 1204 2-s2.0-45749138429 10.1248/bpb.31.1199 (Pubitemid 351871179)
173. Lee K. H., Choi E. M., Stimulatory effects of extract prepared from the bark of Cinnamomum cassia blume on the function of osteoblastic MC3T3-E1 cells. Phytotherapy Research 2006 20 11 952 960 2-s2.0-33751119896 10.1002/ptr.1984 (Pubitemid 44763780)
174. Tang C. H., Huang T. H., Chang C. S., Fu W. M., Yang R. S., Water solution of onion crude powder inhibits RANKL-induced osteoclastogenesis through ERK, p38 and NF- B pathways. Osteoporosis International 2009 20 1 93 103 2-s2.0-57049118500 10.1007/s00198-008-0630-2
175. Mukherjee M., Das A. S., Mitra S., Mitra C., Prevention of bone loss by oil extract of garlic (Allium sativum Linn.) in an ovariectomized rat model of osteoporosis. Phytotherapy Research 2004 18 5 389 394 2-s2.0-2942537998 10.1002/ptr.1448 (Pubitemid 38758242)
176. Nian H., Qin L. P., Chen W. S., Zhang Q. Y., Zheng H. C., Wang Y., Protective effect of steroidal saponins from rhizome of Anemarrhena asphodeloides on ovariectomy-induced bone loss in rats. Acta Pharmacologica Sinica 2006 27 6 728 734 2-s2.0-33745353094 10.1111/j.1745-7254.2006.00328.x (Pubitemid 43943922)
177. Zeng G. F., Zhang Z. Y., Lu L., Xiao D. Q., Xiong C. X., Zhao Y. X., Zong S. H., Protective effects of Polygonatum sibiricum polysaccharide on ovariectomy-induced bone loss in rats. Journal of Ethnopharmacology 2011 136 1 224 229 2-s2.0-79958091440 10.1016/j.jep.2011.04.049
178. Ayoub N., Singab A. N., El-Naggar M., Lindequist U., Investigation of phenolic leaf extract of Heimia myrtifolia (Lythraceae): pharmacological properties (stimulation of mineralization of SaOS-2 osteosarcoma cells) and identification of polyphenols. Drug Discoveries and Therapeutics 2010 4 5 341 348
179. Puel C., Mathey J., Kati-Coulibaly S., Davicco M. J., Lebecque P., Chanteranne B., Horcajada M. N., Coxam V., Preventive effect of Abelmoschus manihot (L.) Medik. on bone loss in the ovariectomised rats. Journal of Ethnopharmacology 2005 99 1 55 60 2-s2.0-17644385862 10.1016/j.jep.2005.01.047 (Pubitemid 40569401)
180. Kapur P., Jarry H., Wuttke W., Pereira B. M. J., Seidlova-Wuttke D., Evaluation of the antiosteoporotic potential of Tinospora cordifolia in female rats. Maturitas 2008 59 4 329 338 2-s2.0-44349133854 10.1016/j.maturitas.2008. 03.006
181. Shuid A. N., Ping L. L., Muhammad N., Mohamed N., Soelaiman I. N., The effects of Labisia pumila var. alata on bone markers and bone calcium in a rat model of post-menopausal osteoporosis. Journal of Ethnopharmacology 2011 133 2 538 542 2-s2.0-78651380656 10.1016/j.jep.2010.10.033
182. Zhang Y., Lai W. P., Leung P. C., Wu C. F., Yao X. S., Wong M. S., Effects of Fructus Ligustri Lucidi extract on bone turnover and calcium balance in ovariectomized rats. Biological and Pharmaceutical Bulletin 2006 29 2 291 296 10.1248/bpb.29.291 (Pubitemid 43200899)
183. Dong X. L., Zhang Y., Favus M. J., Che C. T., Wong M. S., Ethanol extract of Fructus Ligustri Lucidi increases circulating 1,25-dihydroxyvitamin D3 by inducing renal 25-hydroxyvitamin D-1 α hydroxylase activity. Menopause 2010 17 6 1174 1181 2-s2.0-78649673025 10.1097/gme.0b013e3181e39a2b
184. Masuda K., Ikeuchi M., Koyama T., Yamaguchi K., Woo J. T., Nishimura T., Yazawa K., Suppressive effects of Anoectochilus formosanus extract on osteoclast formation in vitro and bone resorption in vivo. Journal of Bone and Mineral Metabolism 2008 26 2 123 129 2-s2.0-39849099796 10.1007/s00774-007-0810-8 (Pubitemid 351317136)
185. Liang H., Yu F., Tong Z., Huang Z., Effect of cistanches herba aqueous extract on bone loss in ovariectomized rat. International Journal of Molecular Sciences 2011 12 8 5060 5069
186. Kim S. W., Kim H. G., Lee B. E., Hwang H. H., Baek D. H., Ko S. Y., Effects of mushroom, Pleurotus eryngii, extracts on bone metabolism. Clinical Nutrition 2006 25 1 166 170 2-s2.0-33144463938 10.1016/j.clnu.2005.10.014 (Pubitemid 43263541)
187. Mori-Okamoto J., Otawara-Hamamoto Y., Yamato H., Yoshimura H., Pomegranate extract improves a depressive state and bone properties in menopausal syndrome model ovariectomized mice. Journal of Ethnopharmacology 2004 92 1 93 101 2-s2.0-1942487864 10.1016/j.jep.2004.02.006 (Pubitemid 38510269)
188. Li J. X., Liu J., He C. C., Yu Z. Y., Du Y., Kadota S., Seto H., Triterpenoids from Cimicifugae rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss. Maturitas 2007 58 1 59 69 2-s2.0-34547935164 10.1016/j.maturitas.2007.06.001 (Pubitemid 47268711)
189. Hooshmand S., Chai S. C., Saadat R. L., Payton M. E., Brummel-Smith K., Arjmandi B. H., Comparative effects of dried plum and dried apple on bone in postmenopausal women. British Journal of Nutrition 2011 106 6 923 930
190. Arjmandi B. H., Johnson C. D., Campbell S. C., Hooshmand S., Chai S. C., Akhter M. P., Combining fructooligosaccharide and dried plum has the greatest effect on restoring bone mineral density among select functional foods and bioactive compounds. Journal of Medicinal Food 2010 13 2 312 319 2-s2.0-77958162928
191. Lee K. H., Choi E. M., Rubus coreanus Miq. extract promotes osteoblast differentiation and inhibits bone-resorbing mediators in MC3T3-E1 cells. American Journal of Chinese Medicine 2006 34 4 643 654 2-s2.0-33749459529 10.1142/S0192415X0600417X (Pubitemid 44515284)
192. Do S. H., Lee J. W., Jeong W. I., Chung J. Y., Park S. J., Hong I. H., Jeon S. K., Lee I. S., Jeong K. S., Bone-protecting effect of Rubus coreanus by dual regulation of osteoblasts and osteoclasts. Menopause 2008 15 4 676 683 2-s2.0-51449105417 10.1097/gme.0b013e31815bb687
193. Kim B. Y., Yoon H. Y., Yun S. I., Woo E. R., Song N. K., Kim H. G., Jeong S. Y., Chung Y. S., In vitro and in vivo inhibition of glucocorticoid-induced osteoporosis by the hexane extract of Poncirus trifoliata. Phytotherapy Research 2011 25 7 1000 1010
194. Deyhim F., Mandadi K., Patil B. S., Faraji B., Grapefruit pulp increases antioxidant status and improves bone quality in orchidectomized rats. Nutrition 2008 24 10 1039 1044 2-s2.0-50549100492 10.1016/j.nut.2008.05.005
195. Deyhim F., Mandadi K., Faraji B., Patil B. S., Grapefruit juice modulates bone quality in rats. Journal of Medicinal Food 2008 11 1 99 104 2-s2.0-41349101171 10.1089/jmf.2007.537 (Pubitemid 351450497)
196. Oh K. O., Kim S. W., Kim J. Y., Ko S. Y., Kim H. M., Baek J. H., Ryoo H. M., Kim J. K., Effect of Rehmannia glutinosa Libosch extracts on bone metabolism. Clinica Chimica Acta 2003 334 1-2 185 195 2-s2.0-12444295412 10.1016/S0009-8981(03)00238-9 (Pubitemid 36836074)
197. Nagareddy P. R., Lakshmana M., Withania somnifera improves bone calcification in calcium-deficient ovariectomized rats. Journal of Pharmacy and Pharmacology 2006 58 4 513 519 2-s2.0-33645557436 10.1211/jpp.58.4.0011 (Pubitemid 44309669)
198. Park C. K., Kim H. J., Kwak H. B., Lee T. H., Bang M. H., Kim C. M., Lee Y., Chung D. K., Baek N. I., Kim J., Lee Z. H., Kim H. H., Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption. International Immunopharmacology 2007 7 12 1507 1516 2-s2.0-34848864363 10.1016/j.intimp.2007.07.016 (Pubitemid 47499256)
199. Kang S. K., Kim K. S., Byun Y. S., Suh S. J., Jim U. H., Kim K. H., Lee I. S., Kim C. H., Effects of Ulmus davidiana planch on mineralization, bone morphogenetic protein-2, alkaline phosphatase, type I collagen, and collagenase-1 in bone cells. In Vitro Cellular and Developmental Biology 2006 42 7 225 229 2-s2.0-33750598969
200. Siddiqui J. A., Sharan K., Swarnkar G., Rawat P., Kumar M., Manickavasagam L., Maurya R., Pierroz D., Chattopadhyay N., Quercetin-6-C- β -d-glucopyranoside isolated from Ulmus wallichiana planchon is more potent than quercetin in inhibiting osteoclastogenesis and mitigating ovariectomy-induced bone loss in rats. Menopause 2011 18 2 198 207 2-s2.0-79951578706 10.1097/gme.0b013e3181e84e67
201. Sharan K., Swarnkar G., Siddiqui J. A., Kumar A., Rawat P., Kumar M., Nagar G. K., Manickavasagam L., Singh S. P., Mishra G., Wahajuddin, Jain G. K., Maurya R., Chattopadhyay N., A novel flavonoid, 6-C- β -d-glucopyranosyl- (2S,3S)-(+)-3′ 4′5,7-tetrahydroxyflavanone, isolated from Ulmus wallichiana Planchon mitigates ovariectomy-induced osteoporosis in rats. Menopause 2010 17 3 577 586 2-s2.0-77952291901 10.1097/gme.0b013e3181d2ce7f
202. Swarnkar G., Sharan K., Siddiqui J. A., Chakravarti B., Rawat P., Kumar M., Arya K. R., Maurya R., Chattopadhyay N., A novel flavonoid isolated from the steam-bark of Ulmus wallichiana Planchon stimulates osteoblast function and inhibits osteoclast and adipocyte differentiation. European Journal of Pharmacology 2011 658 2-3 65 73 2-s2.0-79953796467 10.1016/j.ejphar.2011.02.032
203. Sharan K., Siddiqui J. A., Swarnkar G., Tyagi A. M., Kumar A., Rawat P., Kumar M., Nagar G. K., Arya K. R., Manickavasagam L., Jain G. K., Maurya R., Chattopadhyay N., Extract and fraction from Ulmus wallichiana Planchon promote peak bone achievement and have a nonestrogenic osteoprotective effect. Menopause 2010 17 2 393 402 2-s2.0-77949407107 10.1097/gme.0b013e3181bfae38
204. Sehmisch S., Boeckhoff J., Wille J., Seidlova-Wuttke D., Rack T., Tezval M., Wuttke W., Stuermer K. M., Stuermer E. K., Vitex agnus castus as prophylaxis for osteopenia after orchidectomy in rats compared with estradiol and testosterone supplementation. Phytotherapy Research 2009 23 6 851 858 2-s2.0-67149087354 10.1002/ptr.2711
205. Shirwaikar A., Khan S., Malini S., Antiosteoporotic effect of ethanol extract of Cissus quadrangularis Linn. on ovariectomized rat. Journal of Ethnopharmacology 2003 89 2-3 245 250 2-s2.0-0242637159 10.1016/j.jep.2003.08. 004 (Pubitemid 37378198)
206. Muthusami S., Senthilkumar K., Vignesh C., Ilangovan R., Stanley J., Selvamurugan N., Srinivasan N., Effects of Cissus quadrangularis on the proliferation, differentiation and matrix mineralization of human osteoblast like SaOS-2 cells. Journal of Cellular Biochemistry 2011 112 4 1035 1045 2-s2.0-79952544079 10.1002/jcb.23016
207. Muthusami S., Ramachandran I., Krishnamoorthy S., Govindan R., Narasimhan S., Cissus quadrangularis augments IGF system components in human osteoblast like SaOS-2 cells. Growth Hormone and IGF Research 2011 21 6 343 348
208. Weerachayaphorn J., Chuncharunee A., Mahagita C., Lewchalermwongse B., Suksamrarn A., Piyachaturawat P., A protective effect of Curcuma comosa Roxb. on bone loss in estrogen deficient mice. Journal of Ethnopharmacology 2011 137 2 956 962 2-s2.0-79960880162 10.1016/j.jep.2011.06.040
209. S. Oh, T. W. Kyung, and H. S. Choi, "Curcumin inhibits osteoclastogenesis by decreasing receptor activator of nuclear factor-κB ligand (RANKL) in bone marrow stromal cells," Molecules and Cells, vol. 26, no. 5, pp. 486-489, 2008.